These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19011438)

  • 1. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
    Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
    J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological hyperprolactinemia: a retrospective analysis of 501 hyperprolactinemia cases in primary care setting.
    García Cano AM; Rosillo M; Gómez Lozano A; Jiménez Mendiguchía L; Marchán Pinedo M; Rodríguez Torres A; Araujo-Castro M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3239-3246. PubMed ID: 37910184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of antipsychotic medication and the associated hyperprolactinemia as a risk factor for periodontal diseases in schizophrenic patients: a cohort retrospective study.
    Shalaby R; Elmahdy A; Mikhail C
    BMC Oral Health; 2023 Oct; 23(1):786. PubMed ID: 37875841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term proton pump inhibitors therapy and prevalence of hyperprolactinaemia: A cross-sectional study in outpatient gastroenterology clinics.
    Ashfaq M; Khan AN; Alkahraman YM; Haroon MZ
    J Pak Med Assoc; 2024 Jun; 74(6):1067-1073. PubMed ID: 38948973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary volume in psychosis: the first review of the evidence.
    Pariante CM
    J Psychopharmacol; 2008 Mar; 22(2 Suppl):76-81. PubMed ID: 18709702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Monitoring and Management Practices of Antipsychotic-Induced Hyperprolactinemia at a Medical City in Riyadh, Saudi Arabia: A Retrospective Cohort Study.
    Alshabeeb ZH; Alsuwayni B; Alshargi O; Abdelazeem AH
    Curr Drug Saf; 2024 Mar; ():. PubMed ID: 38485677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Computed Tomographic Findings in Schizophrenia: Relationship to Second-Generation Antipsychotics and Hyperprolactinemia.
    Petric PS; Ifteni P; Popa AV; Teodorescu A
    Healthcare (Basel); 2024 Jul; 12(13):. PubMed ID: 38998877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusually high prolactin level for medication-induced hyperprolactinemia: a case report.
    Akbas EM; Gungor A; Ozdemir C; Bilen H
    Eurasian J Med; 2013 Jun; 45(2):138-40. PubMed ID: 25610268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
    Peuskens J; Pani L; Detraux J; De Hert M
    CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotics-induced hyperprolactinemia and screening for macroprolactin.
    Ruljancic N; Bakliza A; Vuk Pisk S; Geres N; Matic K; Ivezic E; Grosic V; Filipcic I
    Biochem Med (Zagreb); 2021 Feb; 31(1):010707. PubMed ID: 33380894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
    Vilar L; Abucham J; Albuquerque JL; Araujo LA; Azevedo MF; Boguszewski CL; Casulari LA; Cunha Neto MBC; Czepielewski MA; Duarte FHG; Faria MDS; Gadelha MR; Garmes HM; Glezer A; Gurgel MH; Jallad RS; Martins M; Miranda PAC; Montenegro RM; Musolino NRC; Naves LA; Ribeiro-Oliveira Júnior A; Silva CMS; Viecceli C; Bronstein MD
    Arch Endocrinol Metab; 2018; 62(2):236-263. PubMed ID: 29768629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.
    Grigg J; Worsley R; Thew C; Gurvich C; Thomas N; Kulkarni J
    Psychopharmacology (Berl); 2017 Nov; 234(22):3279-3297. PubMed ID: 28889207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials.
    Meng M; Li W; Zhang S; Wang H; Sheng J; Wang J; Li C
    Shanghai Arch Psychiatry; 2015 Feb; 27(1):4-17. PubMed ID: 25852251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The short-term effects of risperidone-induced hyperprolactinemia on lipid metabolism in drug-naïve children and adolescents.
    Park EJ; Park YM
    Psychiatry Investig; 2015 Jan; 12(1):55-60. PubMed ID: 25670946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents.
    Margari L; Matera E; Petruzzelli MG; Simone M; Lamanna AL; Pastore A; Palmieri VO; Margari F
    Int Clin Psychopharmacol; 2015 Mar; 30(2):103-8. PubMed ID: 25514607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of cannulated prolactin test in the definition of hyperprolactinaemia.
    Whyte MB; Pramodh S; Srikugan L; Gilbert JA; Miell JP; Sherwood RA; McGregor AM; Aylwin SJ
    Pituitary; 2015 Jun; 18(3):319-25. PubMed ID: 24879500
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.